Chinese biotech company Ascletis seeks third round of funding that could exceed US$100 millionhttps://buff.ly/2mpFyup
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.